Skip to content

Pioneering a new approach to biological discovery

IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.

"Anti-Integrin antibodies" promotional image.
"Anti-Integrin antibodies" promotional image.

IPI in brief

Drawing Of Microscope.

Meeting research needs

IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Basic Drawing Of Antibody.

Best of both worlds

IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Figure Representing Business Model.

Unique business model

IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Drawing Of Lightbulb.

Cross-disciplinary connections

IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.

Building collaborations

IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.

News from the lab

Innovation comes naturally to IPI’s director of automation Curtis Walton

When Curtis Walton was young, he’d disassemble household items, diligently learning about their inner mechanisms as he reassembled them. Growing up in Sarnia, Ontario, he pulled...

Read more

Epitope tags: Explained

IPI epitope tag antibodies, delivered via an open science model, aim to increase access, cut costs and enhance reproducibility. Maybe this story is yours. You've got...

Read more

IPI’s community-centered approach to antibody discovery: A Q&A with Rob Meijers

This spring, the Institute for Protein Innovation (IPI) dispatched a collection of antibodies targeting members of the elusive integrin receptor family. Those antibodies, shared with researchers...

Read more

Cell signaling, Sonic Hedgehog and Hemingway’s cats: A Q&A with Adrian Salic

In 1980, the famous geneticists Christiane Nüsslein-Volhard and Eric Wieschaus were mapping embryonic mutations in the model organism Drosophila melanogaster, known colloquially as the fruit fly....

Read more

Get in touch today

Back To Top